• 11/11/2024

DSM-Firmenich Earnings Seen Hit by Weak Vitamins

Wall Street Journal

DSM-Firmenich guided for proforma adjusted earnings of up to €1.9 billion in 2023, below the previous year, as it said vitamin prices are expected to remain low until the end of the year.

https://www.wsj.com/articles/dsm-firmenich-sees-lower-adjusted-ebitda-in-2023-on-weak-vitamin-market-2e236072